CORCEPT THERAPEUTICS INC Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
CORCEPT THERAPEUTICS INC (CORT) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $1.38 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2016-03-10
- CORCEPT THERAPEUTICS INC increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2015-12-31 was $425.00K, a 26.11% increase year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2015-09-30 was $325.00K.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2015-06-30 was $88.00K, a 75.07% decline year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2015-03-31 was $543.00K.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accounts payable and accrued liabilities for fiscal 2015 was $1.38M, a 140.17% increase from fiscal 2014.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accounts payable and accrued liabilities for fiscal 2014 was $575.00K, a 125.49% increase from fiscal 2013.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accounts payable and accrued liabilities for fiscal 2013 was $255.00K, a 7.27% decline from fiscal 2012.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accounts payable and accrued liabilities for fiscal 2012 was $275.00K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2015-12-31 | $425.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $750.00K derived: sum of 2 quarters · filed 2016-03-10 | $838.00K derived: sum of 3 quarters · filed 2016-03-10 | $1.38M 10-K · filed 2016-03-10 |
| 2015-09-30 | $325.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $413.00K derived: sum of 2 quarters · filed 2015-11-06 | $956.00K 10-Q · filed 2015-11-06 | $1.29M derived: sum of 4 quarters · filed 2016-03-10 |
| 2015-06-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $631.00K 10-Q · filed 2015-08-07 | $968.00K derived: sum of 3 quarters · filed 2016-03-10 | $883.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2015-03-31 | $543.00K 10-Q · filed 2015-05-08 | $880.00K derived: sum of 2 quarters · filed 2016-03-10 | $795.00K derived: sum of 3 quarters · filed 2016-03-10 | $1.15M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-12-31 | $337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $252.00K derived: sum of 2 quarters · filed 2016-03-10 | $605.00K derived: sum of 3 quarters · filed 2016-03-10 | $575.00K 10-K · filed 2016-03-10 |
| 2014-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $268.00K derived: sum of 2 quarters · filed 2015-11-06 | $238.00K 10-Q · filed 2015-11-06 | $252.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $353.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $323.00K 10-Q · filed 2015-08-07 | $337.00K derived: sum of 3 quarters · filed 2016-03-10 | $309.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | -$30.00K 10-Q · filed 2015-05-08 | -$16.00K derived: sum of 2 quarters · filed 2016-03-10 | -$44.00K derived: sum of 3 quarters · filed 2016-03-10 | -$150.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$14.00K derived: sum of 2 quarters · filed 2016-03-10 | -$120.00K derived: sum of 3 quarters · filed 2016-03-10 | $255.00K 10-K · filed 2016-03-10 |
| 2013-09-30 | -$28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$134.00K derived: sum of 2 quarters · filed 2014-11-07 | $241.00K 10-Q · filed 2014-11-07 | |
| 2013-06-30 | -$106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $269.00K 10-Q · filed 2014-08-08 | ||
| 2013-03-31 | $375.00K 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | $275.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |